Placement of Entitlement Offer Shortfall of approx. $3.20m from institutional and sophisticated investors • Takes the total amount subscribed under the entitlement offer and entitlement offer shortfall placement to $7.66m (before costs) • Current approximate cash position of $15m1 which will fund the advancement of the Company’s clinical trials programs in Glioblastoma, Gastrointestinal Tumours and Acute Myeloid Leukemia
That's BS, they could have filled the 5.5m but Bell Potter looked at the clock instead at the offers coming in throughout the day. Even I increased my offer and got rejected by about 90min too late.
Paul, even if that is not directly your fault, when will you get rid of theses clowns?
CHM Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)